Mounjaro — Revenue
Products & Services · RevenueEli Lilly Mounjaro — Revenue increased by 13.7% to $7.41B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 109.9%, from $3.53B to $7.41B. Over 3 years (FY 2022 to FY 2025), Mounjaro — Revenue shows an upward trend with a 262.4% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates strong market penetration, successful commercial execution, and growing demand for the product, while a decrease may signal increased competition, supply constraints, or loss of market share.
Detailed definition
This metric represents the total gross sales generated from the specific pharmaceutical product line dedicated to cardio...
Peer comparison
Comparable to revenue metrics for blockbuster drug franchises or key growth products at other major pharmaceutical companies like Novo Nordisk or Pfizer.
lly_segment_mounjaro_revenueHistorical Data
| Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $16.00M | $187.30M | $279.20M | $568.50M | $979.70M | $1.41B | $2.21B | $1.81B | $3.09B | $3.11B | $3.53B | $3.84B | $5.20B | $6.52B | $7.41B |
| QoQ Change | — | — | — | >999% | +49.1% | +103.6% | +72.3% | +43.9% | +56.5% | -18.1% | +71.1% | +0.7% | +13.4% | +8.8% | +35.3% | +25.3% | +13.7% |
| YoY Change | — | — | — | — | — | — | >999% | +652.4% | +690.0% | +217.8% | +215.5% | +120.9% | +60.1% | +112.7% | +68.2% | +109.3% | +109.9% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Eli Lilly's mounjaro — revenue?
- Eli Lilly (LLY) reported mounjaro — revenue of $7.41B in Q4 2025.
- How has Eli Lilly's mounjaro — revenue changed year-over-year?
- Eli Lilly's mounjaro — revenue increased by 109.9% year-over-year, from $3.53B to $7.41B.
- What is the long-term trend for Eli Lilly's mounjaro — revenue?
- Over 3 years (2022 to 2025), Eli Lilly's mounjaro — revenue has grown at a 262.4% compound annual growth rate (CAGR), from $482.50M to $22.97B.
- What does mounjaro — revenue mean?
- The total sales revenue generated by the Mounjaro product line.